Laura Cau1, Michael R Williams2, Anna M Butcher2, Teruaki Nakatsuji2, Jeffrey S Kavanaugh3, Joyce Y Cheng2, Faiza Shafiq2, Kyle Higbee2, Tissa R Hata2, Alexander R Horswill4, Richard L Gallo5. 1. Department of Dermatology, University of California San Diego, San Diego, Calif; R&D Department, SILAB, Brive, France. 2. Department of Dermatology, University of California San Diego, San Diego, Calif. 3. Department of Immunology and Microbiology, University of Colorado Anschutz, Medical Campus, Aurora, Colo. 4. Department of Immunology and Microbiology, University of Colorado Anschutz, Medical Campus, Aurora, Colo; Department of Veterans Affairs Eastern Colorado Health Care System, Aurora, Colo. 5. Department of Dermatology, University of California San Diego, San Diego, Calif; Center for Microbiome Innovation, University of California San Diego, San Diego, Calif. Electronic address: rgallo@ucsd.edu.
Abstract
BACKGROUND: Staphylococcus aureus and Staphylococcus epidermidis are the most abundant bacteria found on the skin of patients with atopic dermatitis (AD). S aureus is known to exacerbate AD, whereas S epidermidis has been considered a beneficial commensal organism. OBJECTIVE: In this study, we hypothesized that S epidermidis could promote skin damage in AD by the production of a protease that damages the epidermal barrier. METHODS: The protease activity of S epidermidis isolates was compared with that of other staphylococcal species. The capacity of S epidermidis to degrade the barrier and induce inflammation was examined by using human keratinocyte tissue culture and mouse models. Skin swabs from atopic and healthy adult subjects were analyzed for the presence of S epidermidis genomic DNA and mRNA. RESULTS: S epidermidis strains were observed to produce strong cysteine protease activity when grown at high density. The enzyme responsible for this activity was identified as EcpA, a cysteine protease under quorum sensing control. EcpA was shown to degrade desmoglein-1 and LL-37 in vitro, disrupt the physical barrier, and induce skin inflammation in mice. The abundance of S epidermidis and expression of ecpA mRNA were increased on the skin of some patients with AD, and this correlated with disease severity. Another commensal skin bacterial species, Staphylococcus hominis, can inhibit EcpA production by S epidermidis. CONCLUSION: S epidermidis has commonly been regarded as a beneficial skin microbe, whereas S aureus has been considered deleterious. This study suggests that the overabundance of S epidermidis found on some atopic patients can act similarly to S aureus and damage the skin by expression of a cysteine protease.
BACKGROUND: Staphylococcus aureus and Staphylococcus epidermidis are the most abundant bacteria found on the skin of patients with atopic dermatitis (AD). S aureus is known to exacerbate AD, whereas S epidermidis has been considered a beneficial commensal organism. OBJECTIVE: In this study, we hypothesized that S epidermidis could promote skin damage in AD by the production of a protease that damages the epidermal barrier. METHODS: The protease activity of S epidermidis isolates was compared with that of other staphylococcal species. The capacity of S epidermidis to degrade the barrier and induce inflammation was examined by using human keratinocyte tissue culture and mouse models. Skin swabs from atopic and healthy adult subjects were analyzed for the presence of S epidermidis genomic DNA and mRNA. RESULTS: S epidermidis strains were observed to produce strong cysteine protease activity when grown at high density. The enzyme responsible for this activity was identified as EcpA, a cysteine protease under quorum sensing control. EcpA was shown to degrade desmoglein-1 and LL-37 in vitro, disrupt the physical barrier, and induce skin inflammation in mice. The abundance of S epidermidis and expression of ecpA mRNA were increased on the skin of some patients with AD, and this correlated with disease severity. Another commensal skin bacterial species, Staphylococcus hominis, can inhibit EcpA production by S epidermidis. CONCLUSION: S epidermidis has commonly been regarded as a beneficial skin microbe, whereas S aureus has been considered deleterious. This study suggests that the overabundance of S epidermidis found on some atopic patients can act similarly to S aureus and damage the skin by expression of a cysteine protease.
Authors: Jonathan L Linehan; Oliver J Harrison; Seong-Ji Han; Allyson L Byrd; Ivan Vujkovic-Cvijin; Alejandro V Villarino; Shurjo K Sen; Jahangheer Shaik; Margery Smelkinson; Samira Tamoutounour; Nicholas Collins; Nicolas Bouladoux; Amiran Dzutsev; Stephan P Rosshart; Jesse H Arbuckle; Chyung-Ru Wang; Thomas M Kristie; Barbara Rehermann; Giorgio Trinchieri; Jason M Brenchley; John J O'Shea; Yasmine Belkaid Journal: Cell Date: 2018-01-18 Impact factor: 41.582
Authors: Haiyun Liu; Nathan K Archer; Carly A Dillen; Yu Wang; Alyssa G Ashbaugh; Roger V Ortines; Tracy Kao; Steven K Lee; Shuting S Cai; Robert J Miller; Mark C Marchitto; Emily Zhang; Daniel P Riggins; Roger D Plaut; Scott Stibitz; Raif S Geha; Lloyd S Miller Journal: Cell Host Microbe Date: 2017-11-08 Impact factor: 21.023
Authors: Amy S Paller; Heidi H Kong; Patrick Seed; Shruti Naik; Tiffany C Scharschmidt; Richard L Gallo; Thomas Luger; Alan D Irvine Journal: J Allergy Clin Immunol Date: 2018-11-23 Impact factor: 10.793
Authors: Morgan M Severn; Michael R Williams; Ali Shahbandi; Zoie L Bunch; Laurie M Lyon; Amber Nguyen; Livia S Zaramela; Daniel A Todd; Karsten Zengler; Nadja B Cech; Richard L Gallo; Alexander R Horswill Journal: mBio Date: 2022-05-24 Impact factor: 7.786